Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Dang

Showing results (481-490 of 528) with videos related to

Pageof 53
Sort By:
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|August 23, 2022
Humanized anti-IL-26 monoclonal antibody as a novel targeted therapy for chronic graft-versus-host diseaseRyo Hatano, Takumi Itoh, Haruna Otsuka, et al.
British Journal of Haematology|July 22, 2014
Paclitaxel, topotecan and rituximab: long term outcomes of an effective salvage programme for relapsed or refractory aggressive B-cell non-Hodgkin lymphomaJason R Westin, Peter McLaughlin, Jorge Romaguera, et al.
British Journal of Haematology|June 28, 2013
Long term results of a phase 2 study of vincristine sulfate liposome injection (Marqibo(®) ) substituted for non-liposomal vincristine in cyclophosphamide, doxorubicin, vincristine, prednisone with or without rituximab for patients with untreated aggressive non-Hodgkin lymphomasFredrick Hagemeister, Maria Alma Rodriguez, Steven R Deitcher, et al.
Pediatric Research|October 5, 2019
Defining and distinguishing infant behavioral states using acoustic cry analysis: is colic painful?Joanna J Parga, Sharon Lewin, Juanita Lewis, et al.
Current Organic Synthesis|January 28, 2020
Using Sodium Hydride and Potassium Carbonate as Bases in Synthesis of Substituted 2-Amino-4-aryl-7-propargyloxy-4H-chromene-3-carbonitrilesNguyen D Thanh, Do S Hai, Vu T N Bich, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 9, 2004
Phase II study of denileukin diftitox for relapsed/refractory B-Cell non-Hodgkin's lymphomaNam H Dang, Fredrick B Hagemeister, Barbara Pro, et al.
British Journal of Haematology|July 6, 2017
Randomized, phase 3 trial of inotuzumab ozogamicin plus rituximab versus chemotherapy plus rituximab for relapsed/refractory aggressive B-cell non-Hodgkin lymphomaNam H Dang, Michinori Ogura, Sylvie Castaigne, et al.
Journal of Medical Case Reports|February 1, 2012
Response to sunitinib in combination with proton beam radiation in a patient with chondrosarcoma: a case reportJennifer Dallas, Iman Imanirad, Rajiv Rajani, et al.
British Journal of Cancer|March 15, 2017
First-in-human phase 1 of YS110, a monoclonal antibody directed against CD26 in advanced CD26-expressing cancersEric Angevin, Nicolas Isambert, Véronique Trillet-Lenoir, et al.
Cancer Biology & Therapy|January 24, 2004
Targeting vascular and avascular compartments of tumors with C. novyi-NT and anti-microtubule agentsLong H Dang, Chetan Bettegowda, Nishant Agrawal, et al.
Pageof 53

Showing results (481-490 of 528) with videos related to

Sort By:
Pageof 53
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|August 23, 2022
Humanized anti-IL-26 monoclonal antibody as a novel targeted therapy for chronic graft-versus-host diseaseRyo Hatano, Takumi Itoh, Haruna Otsuka, et al.
British Journal of Haematology|July 22, 2014
Paclitaxel, topotecan and rituximab: long term outcomes of an effective salvage programme for relapsed or refractory aggressive B-cell non-Hodgkin lymphomaJason R Westin, Peter McLaughlin, Jorge Romaguera, et al.
British Journal of Haematology|June 28, 2013
Long term results of a phase 2 study of vincristine sulfate liposome injection (Marqibo(®) ) substituted for non-liposomal vincristine in cyclophosphamide, doxorubicin, vincristine, prednisone with or without rituximab for patients with untreated aggressive non-Hodgkin lymphomasFredrick Hagemeister, Maria Alma Rodriguez, Steven R Deitcher, et al.
Pediatric Research|October 5, 2019
Defining and distinguishing infant behavioral states using acoustic cry analysis: is colic painful?Joanna J Parga, Sharon Lewin, Juanita Lewis, et al.
Current Organic Synthesis|January 28, 2020
Using Sodium Hydride and Potassium Carbonate as Bases in Synthesis of Substituted 2-Amino-4-aryl-7-propargyloxy-4H-chromene-3-carbonitrilesNguyen D Thanh, Do S Hai, Vu T N Bich, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 9, 2004
Phase II study of denileukin diftitox for relapsed/refractory B-Cell non-Hodgkin's lymphomaNam H Dang, Fredrick B Hagemeister, Barbara Pro, et al.
British Journal of Haematology|July 6, 2017
Randomized, phase 3 trial of inotuzumab ozogamicin plus rituximab versus chemotherapy plus rituximab for relapsed/refractory aggressive B-cell non-Hodgkin lymphomaNam H Dang, Michinori Ogura, Sylvie Castaigne, et al.
Journal of Medical Case Reports|February 1, 2012
Response to sunitinib in combination with proton beam radiation in a patient with chondrosarcoma: a case reportJennifer Dallas, Iman Imanirad, Rajiv Rajani, et al.
British Journal of Cancer|March 15, 2017
First-in-human phase 1 of YS110, a monoclonal antibody directed against CD26 in advanced CD26-expressing cancersEric Angevin, Nicolas Isambert, Véronique Trillet-Lenoir, et al.
Cancer Biology & Therapy|January 24, 2004
Targeting vascular and avascular compartments of tumors with C. novyi-NT and anti-microtubule agentsLong H Dang, Chetan Bettegowda, Nishant Agrawal, et al.
Pageof 53